Lale Tokgözoğlu, Turkey
Hacettepe University Cardiology
Moderator of 5 Sessions
Session Type
Joint symposium
Session Time
10:00 - 11:10
Session Evaluation
Option 1
[{"name":"Introduction","mode":"playlist","public":true,"info":{"id":1542,"presentation":"Introduction","session":"ESC-EAS joint symposium - A Deep Dive into ESC\/EAS Dyslipidemia Guidelines","presenter":"Lale Tokg\u00f6zo\u011flu, Turkey","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5284.jpg"},"playlist":[{"name":"Introduction","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/Lale Intro.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/8\/Lale Intro.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/68B3C613.jpg","data":[],"tracks":[]}]},{"name":"How to approach a patient with dyslipidemia without apparent CAD","mode":"playlist","public":true,"info":{"id":1772,"presentation":"How to approach a patient with dyslipidemia without apparent CAD","session":"ESC-EAS joint symposium - A Deep Dive into ESC\/EAS Dyslipidemia Guidelines","presenter":"Baris Gencer, Switzerland","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/Baris Gencer - EAS20 - 1772 - How to approach a patient with dyslipidaemia without apparent CAD.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/8\/Baris Gencer - EAS20 - 1772 - How to approach a patient with dyslipidaemia without apparent CAD.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/5C593835.jpg","data":[],"tracks":[]}]},{"name":"How to approach a patient with dyslipidemia without apparent CAD. What the guideline says.","mode":"playlist","public":true,"info":{"id":1423,"presentation":"How to approach a patient with dyslipidemia without apparent CAD. What the guideline says.","session":"ESC-EAS joint symposium - A Deep Dive into ESC\/EAS Dyslipidemia Guidelines","presenter":"Victoria Delgado, Netherlands","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5317.jpg"},"playlist":[{"name":"How to approach a patient with dyslipidemia without apparent CAD (case by young fellow) What the gui","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/1423.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/8\/1423.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/F95B53DA.jpg","data":[],"tracks":[]}]},{"name":"What is the critical evidence behind the guideline:","mode":"playlist","public":true,"info":{"id":1424,"presentation":"What is the critical evidence behind the guideline:","session":"ESC-EAS joint symposium - A Deep Dive into ESC\/EAS Dyslipidemia Guidelines","presenter":"Alberico Luigi Catapano, Italy","photo":""},"playlist":[{"name":"What is the critical evidence","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/20.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/8\/20.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/685A78AF.jpg","data":[],"tracks":[]}]},{"name":"How to approach a patient with dyslipidemia with CAD","mode":"playlist","public":true,"info":{"id":1773,"presentation":"How to approach a patient with dyslipidemia with CAD","session":"ESC-EAS joint symposium - A Deep Dive into ESC\/EAS Dyslipidemia Guidelines","presenter":"Anna Lebedeva, Russian Federation","photo":""},"playlist":[{"name":"How to approach a patient with dyslipidemia with CAD","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/1773 attempt 1.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/8\/1773 attempt 1.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/F7187F4.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/1773 attempt 1.vtt"}]},{"name":"How to approach a patient with dyslipidemia with CAD (case by young fellow) What the guideline says","mode":"playlist","public":true,"info":{"id":1425,"presentation":"How to approach a patient with dyslipidemia with CAD (case by young fellow) What the guideline says","session":"ESC-EAS joint symposium - A Deep Dive into ESC\/EAS Dyslipidemia Guidelines","presenter":"Fran\u00e7ois Mach, Switzerland","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/99.jpg"},"playlist":[{"name":"Mach- EAS20 - 1425 -How to approach a patient with dyslipidemia with CAD (case by young fellow) Wha","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/1425.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/8\/1425.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/761BA67A.jpg","data":[],"tracks":[]}]},{"name":"What is the critical evidence behind the guideline:","mode":"playlist","public":true,"info":{"id":1426,"presentation":"What is the critical evidence behind the guideline:","session":"ESC-EAS joint symposium - A Deep Dive into ESC\/EAS Dyslipidemia Guidelines","presenter":"Alberico Luigi Catapano, Italy","photo":""},"playlist":[{"name":"1426-What is the critical evidence behind the guideline:","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/EAS201426.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/8\/EAS201426.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/E1EAE43A.jpg","data":[],"tracks":[]}]}]
{"type":2,"code":"aE32Xi09"}
[session]
[presentation]
[presenter]
Session Time
14:00 - 15:30
Session Evaluation
Please enter to our survey here
Session Evaluation
Option 1
[{"name":"Introduction","mode":"playlist","public":true,"info":{"id":1576,"presentation":"Introduction","session":"Targeting lower LDL-C: When and how?","presenter":"Lale Tokg\u00f6zo\u011flu, Turkey","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5284.jpg"},"playlist":[{"name":"1576-Introduction","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/1576-2.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/106\/1576-2.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/B42548F0.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/1576-2.vtt"}]},{"name":"Are the new EAS\/ESC lipids goals reachable in clinical practice?","mode":"playlist","public":true,"info":{"id":1508,"presentation":"Are the new EAS\/ESC lipids goals reachable in clinical practice?","session":"Targeting lower LDL-C: When and how?","presenter":"Fran\u00e7ois Mach, Switzerland","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/99.jpg"},"playlist":[{"name":"Mach - EAS20 - 1508 - Are the new EAS\/ESC lipids goals reachable in clinical practice?","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/1508.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/106\/1508.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/C6C6FA52.jpg","data":[],"tracks":[]}]},{"name":"Risk stratification in very high risk patients is it of value?","mode":"playlist","public":true,"info":{"id":1509,"presentation":"Risk stratification in very high risk patients is it of value?","session":"Targeting lower LDL-C: When and how?","presenter":"Kausik K. Ray, United Kingdom","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/1332.jpg"},"playlist":[{"name":"Kausik Ray - EAS20 - 1509 - Risk stratification in very high risk patients is it of value","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/Kausik Ray - EAS20 - 1509 - Risk stratification in very high risk patients is it of value.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/106\/Kausik Ray - EAS20 - 1509 - Risk stratification in very high risk patients is it of value.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/8A00E2F9.jpg","data":[],"tracks":[]}]},{"name":"An update on the results of ODYSSEY outcomes","mode":"playlist","public":true,"info":{"id":1510,"presentation":"An update on the results of ODYSSEY outcomes","session":"Targeting lower LDL-C: When and how?","presenter":"Philippe G. Steg, France","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5389.jpg"},"playlist":[{"name":"An update on the results of ODYSSEY outcomes","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/1510.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/106\/1510.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/3DEA6236.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/1510.vtt"}]},{"name":"Panel Discussion with Live Q&A","mode":"playlist","public":true,"info":{"id":1577,"presentation":"Panel Discussion with Live Q&A","session":"Targeting lower LDL-C: When and how?","presenter":"David Wood, Ireland, Lale Tokg\u00f6zo\u011flu, Turkey, Fran\u00e7ois Mach, Switzerland, Philippe G. Steg, France, Kausik K. Ray, United Kingdom","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5284.jpg"},"playlist":[{"name":"Targeting lower LDL-C When and how","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/Targeting lower LDL-C When and how.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/106\/Targeting lower LDL-C When and how.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/CAE4AD81.jpg","data":[],"tracks":[]}]}]
{"type":2,"code":"8E32Xi02Q"}
[session]
[presentation]
[presenter]
Session Time
17:30 - 18:30
Session Evaluation
Option 1
[{"name":"Introduction","mode":"playlist","public":true,"info":{"id":1547,"presentation":"Introduction","session":"KEYNOTE LECTURE","presenter":"Lale Tokg\u00f6zo\u011flu, Turkey","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5284.jpg"},"playlist":[{"name":"1547- Introduction","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/12\/12_1547_1.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/12\/12_1547_1.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/12\/B8F21F38.jpg","data":[],"tracks":[]}]},{"name":"Foundations of Immunometabolism and Implications for Metabolic Health and Disease","mode":"playlist","public":true,"info":{"id":1433,"presentation":"Foundations of Immunometabolism and Implications for Metabolic Health and Disease","session":"KEYNOTE LECTURE","presenter":"G\u00f6khan Hotam\u0131\u015fl\u0131gil, United States of America","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5323.jpg"},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/12\/G\u00f6khan Hotamisligil - EAS20-1433-Keynote Foundations of Immunometabolism and Implications for Metabolic Health and Disease.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/12\/G\u00f6khan Hotamisligil - EAS20-1433-Keynote Foundations of Immunometabolism and Implications for Metabolic Health and Disease.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/12\/DB3DF617.jpg","data":[],"tracks":[]}]}]
{"type":2,"code":"9E32Xi0d"}
[session]
[presentation]
[presenter]
Session Type
Joint symposium
Session Time
10:00 - 11:00
Session Evaluation
Option 1
[{"name":"Introduction","mode":"playlist","public":true,"info":{"id":1560,"presentation":"Introduction","session":"EAS-IAS joint session - Celebrating the 60th Anniversary of Atherosclerosis","presenter":"Raul D. Santos, Brazil","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/3700.jpg"},"playlist":[{"name":"1560-Introduction","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/16\/Raul Santos - EAS20 - ID 1560.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/16\/Raul Santos - EAS20 - ID 1560.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/16\/9F3F1B1A.jpg","data":[],"tracks":[]}]},{"name":"Introduction","mode":"playlist","public":true,"info":{"id":1784,"presentation":"Introduction","session":"EAS-IAS joint session - Celebrating the 60th Anniversary of Atherosclerosis","presenter":"Lale Tokg\u00f6zo\u011flu, Turkey","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5284.jpg"},"playlist":[{"name":"Introduction","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/16\/16_1756_2 edited.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/16\/16_1756_2 edited.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/16\/233A9A5B.jpg","data":[],"tracks":[]}]},{"name":"50th and 60th Anniversary of Atherosclerosis and its predecessor Journal of Atherosclerosis Research, respectively","mode":"playlist","public":true,"info":{"id":1756,"presentation":"50th and 60th Anniversary of Atherosclerosis and its predecessor Journal of Atherosclerosis Research, respectively","session":"EAS-IAS joint session - Celebrating the 60th Anniversary of Atherosclerosis","presenter":"Arnold Von Eckardstein, Switzerland","photo":""},"playlist":[{"name":"50th and 60th Anniversary of Atherosclerosis and its predecessor Journal of Atherosclerosis Research","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/16\/Arnold von Eckardstein - EAS20- 1436 - 2 short presentations.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/16\/Arnold von Eckardstein - EAS20- 1436 - 2 short presentations.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/16\/B58A2D07.jpg","data":[],"tracks":[]}]},{"name":"Distribution of macrophage polarization markers in human atherosclerosis","mode":"playlist","public":true,"info":{"id":1437,"presentation":"Distribution of macrophage polarization markers in human atherosclerosis","session":"EAS-IAS joint session - Celebrating the 60th Anniversary of Atherosclerosis","presenter":"Menno De Winther, Netherlands","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/3554.jpg"},"playlist":[{"name":"Distribution of macrophage polarization markers in human atherosclerosis","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/16\/Menno de Winther EAS20 ID1437 Distribution of macrophage polarization markers in human atherosclerosis.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/16\/Menno de Winther EAS20 ID1437 Distribution of macrophage polarization markers in human atherosclerosis.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/16\/56CE8AFE.jpg","data":[],"tracks":[]}]}]
{"type":2,"code":"8E32Xi0h"}
[session]
[presentation]
[presenter]
Date
07.10.2020, Wednesday
Session Time
17:30 - 19:00
Session Evaluation
Option 1
[{"name":"Introduction","mode":"playlist","public":true,"info":{"id":1751,"presentation":"Introduction","session":"Lowering circulating PCSK9 to reduce LDL cholesterol: Current approaches","presenter":"Alberico Luigi Catapano, Italy","photo":""},"playlist":[{"name":"1751-Introduction","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/163\/EAS201751.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/163\/EAS201751.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/163\/38F8677A.jpg","data":[],"tracks":[]}]},{"name":"The biology of PCSK9","mode":"playlist","public":true,"info":{"id":1752,"presentation":"The biology of PCSK9","session":"Lowering circulating PCSK9 to reduce LDL cholesterol: Current approaches","presenter":"Bertrand Cariou, France","photo":""},"playlist":[{"name":"1752-The biology of PCSK9","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/163\/EAS201752.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/163\/EAS201752.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/163\/7F581DAA.jpg","data":[],"tracks":[]}]},{"name":"Monoclonal antibody approaches targeting circulating PCSK9","mode":"playlist","public":true,"info":{"id":1753,"presentation":"Monoclonal antibody approaches targeting circulating PCSK9","session":"Lowering circulating PCSK9 to reduce LDL cholesterol: Current approaches","presenter":"Ulf Landmesser, Germany","photo":""},"playlist":[{"name":"1753-Monoclonal antibody approaches targeting circulating PCSK9","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/163\/EAS20_1753.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/163\/EAS20_1753.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/163\/8CA46531.jpg","data":[],"tracks":[]}]},{"name":"siRNA based approaches targeting hepatic synthesis of PCSK9","mode":"playlist","public":true,"info":{"id":1754,"presentation":"siRNA based approaches targeting hepatic synthesis of PCSK9","session":"Lowering circulating PCSK9 to reduce LDL cholesterol: Current approaches","presenter":"Kausik K. Ray, United Kingdom","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/1332.jpg"},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/163\/Kausik Ray - EAS20 - 1754.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/163\/Kausik Ray - EAS20 - 1754.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/163\/32304323.jpg","data":[],"tracks":[]}]},{"name":"Panel Discussion with Live Q&A","mode":"playlist","public":true,"info":{"id":1755,"presentation":"Panel Discussion with Live Q&A","session":"Lowering circulating PCSK9 to reduce LDL cholesterol: Current approaches","presenter":"Lale Tokg\u00f6zo\u011flu, Turkey, Alberico Luigi Catapano, Italy, Bertrand Cariou, France, Ulf Landmesser, Germany, Kausik K. Ray, United Kingdom","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5284.jpg"},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/163\/Lowering circulating PCSK9 to reduce LDL cholesterol.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/163\/Lowering circulating PCSK9 to reduce LDL cholesterol.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/163\/39D8742F.jpg","data":[],"tracks":[]}]}]
{"type":2,"code":"aE32Xi03P"}
[session]
[presentation]
[presenter]
Presenter of 14 Presentations
Introduction
Session Type
Introduction
Session Time
12:55 - 13:00
Lecture Time
12:55 - 12:55
[{"name":"Introduction","mode":"playlist","public":true,"info":{"id":1783,"presentation":"Introduction","session":"Introduction to the scientific programme","presenter":"Lale Tokg\u00f6zo\u011flu, Turkey","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5284.jpg"},"playlist":[{"name":"Introduction to the scientific programme","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/169\/169 - 1774.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/169\/169 - 1774.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/169\/7A0E1BBB.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"9E22Xi0wK"}
[session]
[presentation]
[presenter]
Introduction
Session Type
Introduction
Session Time
08:00 - 08:05
Lecture Time
08:00 - 08:05
[{"name":"Introduction","mode":"playlist","public":true,"info":{"id":1775,"presentation":"Introduction","session":"Introduction to the scientific programme","presenter":"Lale Tokg\u00f6zo\u011flu, Turkey","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5284.jpg"},"playlist":[{"name":"Introduction_170 - 1775","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/170\/170 - 1775 edtied.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/170\/170 - 1775 edtied.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/170\/EA0F1FC9.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"6E22Xi0wB"}
[session]
[presentation]
[presenter]
Introduction
Session Type
Joint symposium
Session Time
10:00 - 11:00
Lecture Time
10:02 - 10:04
[{"name":"Introduction","mode":"playlist","public":true,"info":{"id":1784,"presentation":"Introduction","session":"EAS-IAS joint session - Celebrating the 60th Anniversary of Atherosclerosis","presenter":"Lale Tokg\u00f6zo\u011flu, Turkey","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5284.jpg"},"playlist":[{"name":"Introduction","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/16\/16_1756_2 edited.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/16\/16_1756_2 edited.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/16\/233A9A5B.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"aE22Xi0wL"}
[session]
[presentation]
[presenter]
Introduction
Session Type
Introduction
Session Time
08:00 - 08:05
Lecture Time
08:00 - 08:05
[{"name":"Introduction","mode":"playlist","public":true,"info":{"id":1776,"presentation":"Introduction","session":"Introduction to the scientific programme","presenter":"Lale Tokg\u00f6zo\u011flu, Turkey","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5284.jpg"},"playlist":[{"name":"Introduction","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/172\/EDIT - 3rd Introduction Tuesday Early Morning.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/172\/EDIT - 3rd Introduction Tuesday Early Morning.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/172\/19C3E8F0.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"7E22Xi0wC"}
[session]
[presentation]
[presenter]
Introduction
Session Type
Introduction
Date
07.10.2020, Wednesday
Session Time
08:00 - 08:05
Lecture Time
08:00 - 08:05
[{"name":"Introduction","mode":"playlist","public":true,"info":{"id":1777,"presentation":"Introduction","session":"Introduction to the scientific programme","presenter":"Lale Tokg\u00f6zo\u011flu, Turkey","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5284.jpg"},"playlist":[{"name":"Introduction","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/173\/EDIT - Ruth Frikke-Schmidt 4th DAY.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/173\/EDIT - Ruth Frikke-Schmidt 4th DAY.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/173\/200593B.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"8E22Xi0wD"}
[session]
[presentation]
[presenter]
Young Investigator and Anitschkow awards
Session Time
19:00 - 20:30
Lecture Time
19:15 - 19:20
[{"name":"Young Investigator and Anitschkow awards","mode":"playlist","public":true,"info":{"id":1779,"presentation":"Young Investigator and Anitschkow awards","session":"Opening Ceremony including Anitschkow Lecture","presenter":"Lale Tokg\u00f6zo\u011flu, Turkey","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5284.jpg"},"playlist":[{"name":"YIA Intro","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/4\/5 - Lale -1779 - YIA Introduction.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/4\/5 - Lale -1779 - YIA Introduction.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/4\/AFA9D3DC.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"aE22Xi0wF"}
[session]
[presentation]
[presenter]
Panel Discussion with Live Q&A
Date
07.10.2020, Wednesday
Session Time
17:30 - 19:00
Lecture Time
18:33 - 18:48
[{"name":"Panel Discussion with Live Q&A","mode":"playlist","public":true,"info":{"id":1755,"presentation":"Panel Discussion with Live Q&A","session":"Lowering circulating PCSK9 to reduce LDL cholesterol: Current approaches","presenter":"Lale Tokg\u00f6zo\u011flu, Turkey, Alberico Luigi Catapano, Italy, Bertrand Cariou, France, Ulf Landmesser, Germany, Kausik K. Ray, United Kingdom","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5284.jpg"},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/163\/Lowering circulating PCSK9 to reduce LDL cholesterol.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/163\/Lowering circulating PCSK9 to reduce LDL cholesterol.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/163\/39D8742F.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"6E22Xi0wg"}
[session]
[presentation]
[presenter]
What is the landscape on lipid management today?
Session Time
17:00 - 18:30
Lecture Time
17:03 - 17:17
[{"name":"What is the landscape on lipid management today?","mode":"playlist","public":true,"info":{"id":1505,"presentation":"What is the landscape on lipid management today?","session":"Novel approaches to lipid lowering management","presenter":"Lale Tokg\u00f6zo\u011flu, Turkey","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5284.jpg"},"playlist":[{"name":"1505 - What is the landscape on lipid management today?","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/105\/105_1505_2.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/105\/105_1505_2.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/105\/593A446A.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"6E22Xi0rX"}
[session]
[presentation]
[presenter]
Panel Discussion with Live Q&A
Session Time
17:00 - 18:30
Lecture Time
17:45 - 18:00
[{"name":"Panel Discussion with Live Q&A","mode":"playlist","public":true,"info":{"id":1581,"presentation":"Panel Discussion with Live Q&A","session":"Novel approaches to lipid lowering management","presenter":"Marja-Riitta Taskinen, Finland, Alberico Luigi Catapano, Italy, Lale Tokg\u00f6zo\u011flu, Turkey, Ulrich Laufs, Germany, Kausik K. Ray, United Kingdom","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5369.jpg"},"playlist":[{"name":"Novel approaches to lipid lowering management","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/105\/Novel approaches to lipid lowering management.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/105\/Novel approaches to lipid lowering management.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/105\/D568E245.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"7E22Xi0tg"}
[session]
[presentation]
[presenter]
Welcome by EAS President
Session Time
19:00 - 20:30
Lecture Time
19:00 - 19:05
[{"name":"Welcome by EAS President","mode":"playlist","public":true,"info":{"id":1568,"presentation":"Welcome by EAS President","session":"Opening Ceremony including Anitschkow Lecture","presenter":"Lale Tokg\u00f6zo\u011flu, Turkey","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5284.jpg"},"playlist":[{"name":"Welcome by President","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/4\/1 - Lale - 1568 - Geneva Movie Introduction.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/4\/1 - Lale - 1568 - Geneva Movie Introduction.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/4\/CFBF13D3.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"9E22Xi0t3"}
[session]
[presentation]
[presenter]
Introduction
Session Type
Joint symposium
Session Time
10:00 - 11:10
Lecture Time
10:00 - 10:03
[{"name":"Introduction","mode":"playlist","public":true,"info":{"id":1542,"presentation":"Introduction","session":"ESC-EAS joint symposium - A Deep Dive into ESC\/EAS Dyslipidemia Guidelines","presenter":"Lale Tokg\u00f6zo\u011flu, Turkey","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5284.jpg"},"playlist":[{"name":"Introduction","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/Lale Intro.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/8\/Lale Intro.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/68B3C613.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"8E22Xi0sA"}
[session]
[presentation]
[presenter]
Introduction
Session Time
14:00 - 15:30
Lecture Time
14:00 - 14:03
[{"name":"Introduction","mode":"playlist","public":true,"info":{"id":1576,"presentation":"Introduction","session":"Targeting lower LDL-C: When and how?","presenter":"Lale Tokg\u00f6zo\u011flu, Turkey","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5284.jpg"},"playlist":[{"name":"1576-Introduction","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/1576-2.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/106\/1576-2.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/B42548F0.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/1576-2.vtt"}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"7E22Xi0tb"}
[session]
[presentation]
[presenter]
Panel Discussion with Live Q&A
Session Time
14:00 - 15:30
Lecture Time
15:15 - 15:30
[{"name":"Panel Discussion with Live Q&A","mode":"playlist","public":true,"info":{"id":1577,"presentation":"Panel Discussion with Live Q&A","session":"Targeting lower LDL-C: When and how?","presenter":"David Wood, Ireland, Lale Tokg\u00f6zo\u011flu, Turkey, Fran\u00e7ois Mach, Switzerland, Philippe G. Steg, France, Kausik K. Ray, United Kingdom","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5284.jpg"},"playlist":[{"name":"Targeting lower LDL-C When and how","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/Targeting lower LDL-C When and how.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/106\/Targeting lower LDL-C When and how.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/CAE4AD81.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"8E22Xi0tc"}
[session]
[presentation]
[presenter]
Introduction
Session Time
17:30 - 18:30
Lecture Time
17:30 - 17:33
[{"name":"Introduction","mode":"playlist","public":true,"info":{"id":1547,"presentation":"Introduction","session":"KEYNOTE LECTURE","presenter":"Lale Tokg\u00f6zo\u011flu, Turkey","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5284.jpg"},"playlist":[{"name":"1547- Introduction","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/12\/12_1547_1.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/12\/12_1547_1.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/12\/B8F21F38.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"8E22Xi0sF"}
[session]
[presentation]
[presenter]
